Australia - English - Department of Health (Therapeutic Goods Administration)

mundipharma pty ltd - morphine sulfate pentahydrate -

Australia - English - Department of Health (Therapeutic Goods Administration)

mundipharma pty ltd - morphine sulfate pentahydrate -

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

freezone public health pty ltd - bifenthrin; n-methyl-2-pyrrolidone; liquid hydrocarbon - emulsifiable concentrate - bifenthrin pyrethroid active 100.0 g/l; n-methyl-2-pyrrolidone solvent other 50.0 g/l; liquid hydrocarbon solvent other 562.0 g/l - insecticide - apricot | banana | barley | canola | citrus | clover | commercial building/structure - external | cotton | domestic building/str - african black beetle | ant | apple dimpling bug - c. liebknechti | argentine stem weevil | banana rust thrip | banana weevil borer | bill bug | black or black house ant | blue oat or pea mite | brown pasture looper | bryobia mite - bryobia spp. | carmine mite | carpophilus beetle | citrus leaf-eating weevil | coastal brown ant | cockroach | corn earworm | cotton budworm or bollworm | false wireworm | fig longicorn | flea | fly | funnel ant | green mirid bug | lawn armyworm | longtailed mealy bug | meat ant | mosquito | native budworm or bollworm | paper nest wasp | pasture webworm | redlegged earth mite | sod webworm | spider | stinging ant | strawberry spider mite | subterranean termite - coptotermes spp. | sugar ant | sugarcane wireworm - agrypnus variabilis | tick | tick - except paralysis tick | tomato russet mite | two spotted mite | vegetable weevil | whitefly | adult mosquitoes | argentine ant | banana spider mite | banded sugar ant | billbug | campylomma livida | coptotermes acinaciformis | coptoterme

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

ccd animal health pty ltd - oxytetracycline hydrochloride - oral powder, pre-mix - oxytetracycline hydrochloride antibiotic active 10.0 g/kg - antibiotic & related - calf | honey bees | pigs | poultry | beef calf | boar | bovine | breeders | broiler | calf - poddy | calf - preweaning | calf - - bacterial calf scours | bacterial enteritis | chronic respiratory disease complex | colibacillosis | coryza | dermatitis | diptheria | european brood disease | infectious sinusitis | infectious synovitis | necrotic enteritis | oedema | pasteurella multocida | pasteurella spp. | pneumonia | salmonellosis | bacterial pneumonia | discharging sinuses | european foulbrood | fowl cholera | gangrenous | infectious coryza | ms | pasterellosis | pasteurellosis | physiological of the mammary g | post-weaning bacterial enterit | skin disorder

Australia - English - Department of Health (Therapeutic Goods Administration)

neolife international pty ltd - glycine max, quantity: 225 mg (equivalent: linolenic acid, qty 16.65 mg); triticum aestivum, quantity: 150 mg (equivalent: gluten, qty 0 mg); triticum aestivum, quantity: 10 mg (equivalent: gluten, qty 0.004 mg); oryza sativa, quantity: 300 mg; oryza sativa, quantity: 10 mg; mixed (high-alpha type) tocopherols concentrate, quantity: 2 mg - capsule, soft - excipient ingredients: gelatin; yellow beeswax; titanium dioxide; chlorophyllin-copper complex; purified water; glycerol - antioxidant/reduce free radicals formed in the body ; maintain/support body metabolism/metabolic rate ; maintain/support energy production ; maintain/support eye health ; maintain/support healthy teeth ; anti-inflammatory/relieve inflammation ; maintain/support connective tissue health ; helps enhance/promote bone health ; maintain/support bone health ; helps enhance/promote healthy joint function ; maintain/support joint health ; maintain/support cardiovascular system health ; maintain/support healthy cardiovascular system function ; maintain/support heart health ; maintain/support immune system health ; maintain/support healthy immune system function ; maintain/support muscle health ; maintain/support muscle function ; helps maintain/support cellular uptake of (state vitamin/mineral/nutrient) ; helps prevent dietary (state vitamin/mineral/nutrient) deficiency ; maintain/support brain function ; maintain/support nervous system health ; maintain/support nervous system function

Australia - English - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - moxifloxacin hydrochloride, quantity: 1.74 mg/ml - injection, intravenous infusion - excipient ingredients: sodium hydroxide; hydrochloric acid; water for injections; sodium chloride - moxifloxacin-baxter is indicated for treatment of adults who require initial i.v. therapy for the treatment of infections in the conditions: ? community acquired pneumonia (caused by susceptible organisms) ? acute exacerbations of chronic bronchitis when caused by organisms bacteriologically proven to be resistant to other classes of antibiotics or when there is intolerance to other antibiotics moxifloxacin-baxter is indicated for treatment of adults with severe and complicated skin and skin structure infections who require initial parenteral therapy, and who have intolerance to alternative agents, (especially penicillin allergy), and when caused by organisms known to be susceptible to moxifloxacin. appropriate culture and susceptibility tests should be performed before treatment in order to isolate and identify organisms causing infection and to determine their susceptibility to moxifloxacin. therapy with moxifloxacin-baxter may be initiated, in some conditions, before results of these tests are known. once results become available, therapy should be continued with the most appropriate antibiotic therapy.

Australia - English - Department of Health (Therapeutic Goods Administration)

merck healthcare pty ltd - cladribine, quantity: 10 mg - tablet, uncoated - excipient ingredients: hydroxypropylbetadex; sorbitol; magnesium stearate - mavenclad is indicated for the treatment of relapsing-remitting multiple sclerosis (rrms) to reduce the frequency of clinical relapses and to delay the progression of physical disability.,following completion of the 2 treatment courses, no further cladribine treatment is required in years 3 and 4. re-initiation of therapy after year 4 has not been studied.

Australia - English - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - teriflunomide, quantity: 14 mg - tablet, film coated - excipient ingredients: magnesium stearate; colloidal anhydrous silica; maize starch; lactose monohydrate; sodium starch glycollate type a; microcrystalline cellulose; hyprolose; titanium dioxide; macrogol 8000; hypromellose; purified talc; indigo carmine aluminium lake - teriflunomide tablets are indicated for the treatment of patients with relapsing forms of multiple sclerosis to reduce the frequency of clinical relapses and to delay the progression of physical disability.

Australia - English - Department of Health (Therapeutic Goods Administration)

zimmer biomet pty ltd - 34190 - uncoated hip femur prosthesis, modular - highly polished stainless steel (protasul?-s30)femoral stem component used in conjunction with a femoral head component for replacement of the proximal femur in total hip arthroplasty. a 12/14 taper is incorporated in the design of the stem to interlock it with the femoral head. it is intended for cemented use only. -noninflammatory degenerative joint disease (nidjd), e.g. avascular necrosis, osteoarthritis, and inflammatory joint disease (ijd), e.g. rheumatoid arthritis. -failed previous surgery where pain, deformity, or dysfunction persists. -revision of previously failed hip arthroplasty.

Australia - English - Department of Health (Therapeutic Goods Administration)

aimedical international pty ltd - 61160 - magnetic neural stimulation system, stationary - to stimulate the central or peripheral nervous system by using magnetic stimulation, either by application to the cerebral cortex or peripheral nervous system